Antares Pharma, Inc.
(NASDAQ : ATRS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Loading ATRS News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
BCRC. R. Bard, Inc.
0.73%307.821.6%$420.79m
ABTAbbott Laboratories
0.00%43.650.8%$303.99m
ISRGIntuitive Surgical, Inc.
-0.08%835.877.5%$303.78m
MDTMedtronic PLC
-0.06%83.080.6%$300.49m
BDXBecton, Dickinson and Company
2.47%187.061.3%$288.66m
TMOThermo Fisher Scientific Inc.
-0.85%165.281.0%$272.30m
BSXBoston Scientific Corporation
0.78%26.391.1%$204.45m
BAXBaxter International Inc.
0.47%55.681.7%$202.35m
EWEdwards Lifesciences Corporation
0.01%109.681.2%$201.37m
SYKStryker Corporation
0.74%136.371.3%$138.99m
ZBHZimmer Biomet Holdings, Inc.
1.27%119.601.7%$132.37m
ALGNAlign Technology, Inc.
12.10%134.626.2%$109.43m
HOLXHologic, Inc.
1.28%45.151.6%$99.88m
VARVarian Medical Systems, Inc.
1.97%90.778.8%$98.62m
IDXXIDEXX Laboratories, Inc.
3.05%167.733.7%$95.19m

Company Profile

Antares Pharma, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. It has one operating segment, drug delivery, which includes the development of injection devices and injection based pharmaceutical products as well as transdermal gel products. The company was founded in 1979 and is headquartered in Ewing, NJ.